Hostname: page-component-89b8bd64d-46n74 Total loading time: 0 Render date: 2026-05-09T06:42:19.541Z Has data issue: false hasContentIssue false

Mindfulness-based cognitive therapy v. treatment as usual in adults with ADHD: a multicentre, single-blind, randomised controlled trial

Published online by Cambridge University Press:  28 February 2018

Lotte Janssen*
Affiliation:
Department of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands
Cornelis C. Kan
Affiliation:
Department of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands
Pieter J. Carpentier
Affiliation:
Reinier van Arkel, ‘s-Hertogenbosch, The Netherlands
Bram Sizoo
Affiliation:
Dimence, Deventer, The Netherlands
Sevket Hepark
Affiliation:
Department of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands
Melanie P.J. Schellekens
Affiliation:
Department of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands
A. Rogier T. Donders
Affiliation:
Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands
Jan K. Buitelaar
Affiliation:
Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands Karakter Child and Adolescent Psychiatry, Nijmegen, The Netherlands
Anne E.M. Speckens
Affiliation:
Department of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands
*
Author for correspondence: Lotte Janssen, E-mail: lotte.janssen@radboudumc.nl

Abstract

Background

There is a high need for evidence-based psychosocial treatments for adult attention-deficit hyperactivity disorder (ADHD) to offer alongside treatment as usual (TAU). Mindfulness-based cognitive therapy (MBCT) is a promising psychosocial treatment. This trial investigated the efficacy of MBCT + TAU v. TAU in reducing core symptoms in adults with ADHD.

Methods

A multicentre, single-blind, randomised controlled trial (ClinicalTrials.gov: NCT02463396). Participants were randomly assigned to MBCT + TAU (n = 60), an 8-weekly group therapy including meditation exercises, psychoeducation and group discussions, or TAU only (n = 60), which reflected usual treatment in the Netherlands and included pharmacotherapy and/or psychoeducation. Primary outcome was ADHD symptoms rated by blinded clinicians. Secondary outcomes included self-reported ADHD symptoms, executive functioning, mindfulness skills, self-compassion, positive mental health and general functioning. Outcomes were assessed at baseline, post-treatment, 3- and 6-month follow-up. Post-treatment effects at group and individual level, and follow-up effects were examined.

Results

In MBCT + TAU patients, a significant reduction of clinician-rated ADHD symptoms was found at post-treatment [M difference = −3.44 (−5.75, −1.11), p = 0.004, d = 0.41]. This effect was maintained until 6-month follow-up. More MBCT + TAU (27%) than TAU participants (4%) showed a ⩽30% reduction of ADHD symptoms (p = 0.001). MBCT + TAU patients compared with TAU patients also reported significant improvements in ADHD symptoms, mindfulness skills, self-compassion and positive mental health at post-treatment, which were maintained until 6-month follow-up. Although patients in MBCT + TAU compared with TAU reported no improvement in executive functioning at post-treatment, they did report improvement at 6-month follow-up.

Conclusions

MBCT might be a valuable treatment option alongside TAU for adult ADHD aimed at alleviating symptoms.

Information

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Supplementary material: File

Janssen et al. supplementary material

Janssen et al. supplementary material 1

Download Janssen et al. supplementary material(File)
File 69.5 KB